These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30389594)

  • 21. Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes.
    Aryal B; Rao VA
    PLoS One; 2016; 11(7):e0158376. PubMed ID: 27434059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
    Chowdhury A; Aich A; Jain G; Wozny K; Lüchtenborg C; Hartmann M; Bernhard O; Balleiniger M; Alfar EA; Zieseniss A; Toischer K; Guan K; Rizzoli SO; Brügger B; Fischer A; Katschinski DM; Rehling P; Dudek J
    Cell Rep; 2018 Oct; 25(3):561-570.e6. PubMed ID: 30332638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells.
    Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA
    J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
    Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
    Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?
    Ren M; Miller PC; Schlame M; Phoon CKL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1183-H1193. PubMed ID: 31603701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome.
    Dudek J; Cheng IF; Chowdhury A; Wozny K; Balleininger M; Reinhold R; Grunau S; Callegari S; Toischer K; Wanders RJ; Hasenfuß G; Brügger B; Guan K; Rehling P
    EMBO Mol Med; 2016 Feb; 8(2):139-54. PubMed ID: 26697888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome.
    Dinca AA; Chien WM; Chin MT
    J Mol Cell Cardiol; 2018 Jan; 114():83-92. PubMed ID: 29129703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts.
    He Q; Wang M; Harris N; Han X
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1332-43. PubMed ID: 23997105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.
    Bertero E; Kutschka I; Maack C; Dudek J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165803. PubMed ID: 32348916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.
    Garlid AO; Schaffer CT; Kim J; Bhatt H; Guevara-Gonzalez V; Ping P
    Gene; 2020 Feb; 726():144148. PubMed ID: 31647997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental models of Barth syndrome.
    Pu WT
    J Inherit Metab Dis; 2022 Jan; 45(1):72-81. PubMed ID: 34370877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Drosophila model of Barth syndrome.
    Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulating the sir2-spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome.
    Damschroder D; Zapata-Pérez R; Richardson K; Vaz FM; Houtkooper RH; Wessells R
    Dis Model Mech; 2022 Oct; 15(10):. PubMed ID: 36107830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling.
    Shilovsky GA; Zverkov OA; Seliverstov AV; Ashapkin VV; Putyatina TS; Rubanov LI; Lyubetsky VA
    Oxid Med Cell Longev; 2019; 2019():2901057. PubMed ID: 31781330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome.
    Chowdhury A; Boshnakovska A; Aich A; Methi A; Vergel Leon AM; Silbern I; Lüchtenborg C; Cyganek L; Prochazka J; Sedlacek R; Lindovsky J; Wachs D; Nichtova Z; Zudova D; Koubkova G; Fischer A; Urlaub H; Brügger B; Katschinski DM; Dudek J; Rehling P
    EMBO Mol Med; 2023 Sep; 15(9):e17399. PubMed ID: 37533404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.